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Abstract
A novel molecular beacon-based ﬂuorescence in situ hybridization
(FISH) test allowing for the identiﬁcation of a wide range of
bacterial pathogens directly in positive blood cultures (BCs) was
evaluated with positive BCs of 152 patients. Depending on the
Gram stain, either a Gram-negative or a Gram-positive panel was
used. The time to result was 30 min, and the hands-on time was
only 10 min. Seven per cent of the cultured microorganisms were
not included in the FISH panels; the identiﬁcation rate of those
included was 95.2%. Overall, the FISH test enabled accurate
pathogen identiﬁcation in 88.2% of all cases analysed.
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Blood culture (BC) still represents the reference standard for
the detection and identiﬁcation of bloodstream pathogens [1].
In routine clinical practice, as soon as growth is detected in a
BC bottle, a Gram stain is performed [2]. With conventional
microbiological techniques, it usually takes several hours or
even days from the time of microscopy to deﬁnite pathogen
identiﬁcation [2]. On the other hand, the importance of rapid
diagnosis of sepsis and septic shock allowing for adequate
therapeutic measures such as the initiation or adjustment of a
targeted treatment has been well documented [3,4]. Apart
from molecular technologies for the detection of pathogen
DNA directly from whole blood specimens [5–7], laboratory
methods accelerating the deﬁnite identiﬁcation of microor-
ganisms grown in BCs are also of crucial importance, and have
been the subject of intensive research and development during
recent years [8–16].
Today, in addition to a multitude of home-made molecular
assays, several commercially available tests already exist,
allowing for a culture-independent identiﬁcation of pathogens
grown in BCs. Molecular tests based on multiplex PCR
accurately detect bloodstream pathogens accounting for >90%
of sepsis episodes; moreover, detection of important resis-
tance markers, such as those for methicillin in staphylococci
and those for vancomycin in enterococci, may also be feasible
[8,9]. However, considering the time to result of >4 h, the
prolonged hands-on time, and the high risk of DNA contam-
ination, the usefulness of these tests in daily laboratory routine
may be questionable. With due consideration of time and cost
savings, matrix-assisted laser desorption ionization time-of-
ﬂight mass spectrometry (MALDI-TOF MS), e.g. with the
Sepsityper kit (Bruker Daltonics, Bremen, Germany), may
represent the method of choice allowing for direct pathogen
identiﬁcation in >80% of positive BCs [10]; the main drawbacks
of this method are the cost of acquisition of the system,
meaning that it is affordable only for larger laboratories, and
the exclusive assignment for research use. Other tests for
rapid isolate identiﬁcation in positive BCs, such as the tube
coagulase test, Staphylococcus aureus real-time PCR, including
detection of methicillin resistance, antigen detection (e.g. for
Streptococcus pneumoniae), and molecular ﬂuorescence in situ
hybridization (FISH) assays, are appropriate for integration
into daily routine analysis [11–16]; however, they are only
capable of detecting either a single pathogen or a limited
number of microorganisms.
Here, we evaluated a novel commercially available FISH
assay (hemoFISH; Miacom Diagnostics, D€usseldorf, Germany)
allowing for the direct identiﬁcation of a wide range of
Gram-positive and Gram-negative bloodstream pathogens in
positive BCs accounting for more than 90% and 80% of cases,
respectively (Fig. 1) [17,18]. The test uses molecular beacons
as DNA probes binding to the rRNA of microbial ribosomes.
Analysis was conducted during a period of three months. One
positive BC per patient of consecutive patients was analysed by
FISH with the bottle (aerobic FA or anaerobic FN) becoming
positive ﬁrst with the BacT ALERT 3D system (BioMerieux,
Marcy l’Etoile, France). In the case of neonates and infants, only
the paediatric PF bottle was available. Samples were stored at
room temperature until FISH analysis, which was performed
once daily. The test was performed by an experienced
technician, who was aware only of the Gram stain result.
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Depending on the latter, either a Gram-negative or a
Gram-positive panel was used (Fig. 1), as recommended by
the manufacturer. Brieﬂy, 10 lL of a 1/20 dilution of a BC
aliquot was applied to each of the eight ﬁelds on a microscopy
slide. After being dried on a heat block, bacterial cells were
perforated with lysis buffer and ﬁxed in an ethanol bath, prior
to a 10-min hybridization step with the ﬂuorescent DNA
probes. After termination of the reaction by brieﬂy dipping the
slide in a stop buffer, mounting medium was added, and reading
was performed on a ﬂuorescence microscope (Olympus
BX41; Olympus Deutschland, Hamburg, Germany) equipped
with rhodamine and ﬂuorescein ﬁlters. The time to result was
30 min, and the hands-on time only 10 min.
As for Enterobacteriaceae, ﬂuorescence should not be
limited to the species-speciﬁc ﬁeld, if available, but should
also include the ﬁeld of the family-speciﬁc probe. Similarly,
the ﬁeld of the respective genus-speciﬁc probe should
be also positive with Staphylococcus aureus or Streptococcus
pneumoniae, Streptococcus agalactiae, and Streptococcus pyogenes
(Fig. 1). Subcultured isolates were routinely identiﬁed to the
species level by MALDI-TOF MS (microﬂex; Bruker Dalton-
ics). When MALDI-TOF MS identiﬁcation failed or was not
certain, molecular identiﬁcation with a broad-range PCR and
sequence-analysis protocol was performed, as described
previously [19]. Streptococcus pneumoniae isolates were always
conﬁrmed by optochin testing. This study was approved by the
institutional review board at the Medical University Vienna.
During the evaluation period, 157 bacterial isolates (59
Gram-negatives and 98 Gram-positives) were identiﬁed from
152 positive BCs analysed by FISH. Eleven of 157 micro-
organisms (7%) were not included in the FISH panels, and in
one case staphylococci were not detected, because only the
Gram-negative panel was used, owing to overgrowth by
Bacteroides stercoris (Table 1). Of the remaining 145 microor-
ganisms, 138 were identiﬁed correctly, three were misidenti-
ﬁed, two were identiﬁed to the family but not to the species
level, although the species-speciﬁc probes were included in the
panel, and one was not identiﬁed at all by FISH (Table 1). In
only one case of Enterococcus faecalis monoculture, ﬂuores-
cence was also detected with the speciﬁc DNA probe for
Streptococcus agalactiae (but not with that for the genus
Streptococcus), suggesting cross-reactivity (Table 1). In cases of
discrepancy between FISH and the result obtained routinely,
the latter was conﬁrmed by molecular analysis of the
respective isolate. Overall, the FISH test identiﬁcation rate
for microorganisms contained in the FISH panels was 95.2%
(138/145; 95% CI 90.3–98%). The identiﬁcation rates with the
Gram-negative and Gram-positive panels were 92.7% (51/55;
95% CI 82.4–98%) and 96.7% (87/90; 95% CI 90.6–99.3%),
respectively. There was no appreciable difference in test
performance between aerobic and anaerobic BC bottles (data
not shown). The somewhat lower performance of the
Gram-negative panel was solely attributable to incorrect or
insufﬁcient identiﬁcation of some isolates of the genus
Klebsiella. Beyond that, it would be useful if the Gram-negative
panel also allowed for the detection of the genera Acinetobacter
and Enterobacter; regarding the latter genus, however, an
isolate belonging to the family Enterobacteriaceae, without
belonging to any of the species identiﬁed by this panel, is very
likely to produce chromosomal AmpC b-lactamases, and thus
show a predictable resistance pattern [20].
Overall, the FISH test enabled accurate pathogen identiﬁ-
cation in 88.2% (134/152) of all analysed cases of bacterial
growth in the BC. We believe that, because of the fast and
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FIG. 1. Slide composition of the Gram-negative and Gram-positive panels.
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ﬂexible analytical procedure, this test can be integrated into
the daily routine and repeatedly performed during the day for
early BC diagnostic purposes. Furthermore, it may represent a
useful complementary test to MALDI-TOF MS if the latter is
used for direct pathogen identiﬁcation in positive BCs.
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